Marinus Pharmaceuticals (MRNS) Earnings Date, Estimates & Call Transcripts $0.55 0.00 (-0.16%) As of 02/11/2025 Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Marinus Pharmaceuticals Earnings Summary Marinus Pharmaceuticals posted Q2 2024 earnings on August 13, 2024, reporting an EPS of -$0.60, which missed the consensus estimate of -$0.59 by $0.01. Quarterly revenue was reported to be $8.06 million, below analyst estimates of $9.05 million. With a trailing EPS of -$2.47, Marinus Pharmaceuticals' earnings are expected to grow next year, from ($1.99) to ($0.49) per share. Upcoming Q3 Earnings DateAug. 11Before Market OpensEstimatedConsensus EPS (Aug. 13) -$0.59 Actual EPS (Aug. 13) -$0.60 Missed By -$0.01 Actual Revenue (Aug. 13) $8.06MQ2 2024 Earnings ResourcesQ2 2024 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)MRNS Upcoming EarningsMarinus Pharmaceuticals' next earnings date is estimated for Monday, August 11, 2025, based on past reporting schedules. Powered by Get Marinus Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Marinus Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMRNS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MRNS Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Marinus Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.18-$0.18-$0.18Q2 20251-$0.15-$0.15-$0.15Q3 20251-$0.13-$0.13-$0.13Q4 20251$0.04$0.04$0.04 Marinus Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/11/2025(Estimated)--------8/13/2024Q2 2024-$0.59-$0.60 -$0.01-$0.57$9.05M$8.06M5/8/2024Q1 2024-$0.68-$0.68--$0.68$8.61M$7.68M3/5/2024Q4 2023-$0.64-$0.74 -$0.10-$0.74$7.78M$7.19M11/7/2023Q3 2023-$0.67-$0.61+$0.06-$0.61$6.54M$7.34M8/10/2023Q2 2023-$0.76-$0.61+$0.15-$0.61$5.14M$6.08M Marinus Pharmaceuticals Earnings - Frequently Asked Questions When is Marinus Pharmaceuticals' earnings date? Marinus Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based off last year's report dates. Learn more on MRNS's earnings history. Did Marinus Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Marinus Pharmaceuticals (NASDAQ:MRNS) missed the analysts' consensus estimate of ($0.59) by $0.01 with a reported earnings per share (EPS) of ($0.60). Learn more on analysts' earnings estimate vs. MRNS's actual earnings. How can I listen to Marinus Pharmaceuticals' earnings conference call? The conference call for Marinus Pharmaceuticals' latest earnings report can be listened to online. Listen to Conference Call How can I read Marinus Pharmaceuticals' conference call transcript? The conference call transcript for Marinus Pharmaceuticals' latest earnings report can be read online. Read Transcript How much revenue does Marinus Pharmaceuticals generate each year? Marinus Pharmaceuticals (NASDAQ:MRNS) has a recorded annual revenue of $30.99 million. How much profit does Marinus Pharmaceuticals generate each year? Marinus Pharmaceuticals (NASDAQ:MRNS) has a recorded net income of -$141.40 million. MRNS has generated -$2.47 earnings per share over the last four quarters. What is Marinus Pharmaceuticals' EPS forecast for next year? Marinus Pharmaceuticals' earnings are expected to grow from ($1.99) per share to ($0.49) per share in the next year. More Earnings Resources from MarketBeat Related Companies NMRA Earnings Date GLSI Earnings Date THTX Earnings Date ANIX Earnings Date BHST Earnings Date TARA Earnings Date HURA Earnings Date BYSI Earnings Date KRRO Earnings Date PLX Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:MRNS) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marinus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marinus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MRNS Stock Alerts